Zimmer Holdings was told to pay $70 million to Stryker for patent infringements, according to Bloomberg Businessweek. A federal jury in Grand Rapids, Mich., found that Zimmer willfully infringed on patents for devices that use pulsing liquid to clean bones during joint replacement surgery, according to the report.
Stryker's claim called out the Zimmer Pulsavac products, which made $386 million in sales last year.
Zimmer plans to appeal the verdict.
More Articles on Devices:
Victrex Looks for Market Growth in 2013
CareFusion Files 2012 Fiscal Form, $3.6B FY Revenue Reported
Former Synthes Chair Donates $2M to Establish Orthopedic Endowment
Stryker's claim called out the Zimmer Pulsavac products, which made $386 million in sales last year.
Zimmer plans to appeal the verdict.
More Articles on Devices:
Victrex Looks for Market Growth in 2013
CareFusion Files 2012 Fiscal Form, $3.6B FY Revenue Reported
Former Synthes Chair Donates $2M to Establish Orthopedic Endowment